Much of the work carried out by DTT is in support of the National Toxicology Program (NTP), an interagency partnership of the Food and Drug Administration, National Institute for Occupational Safety and Health, and NIEHS.Visit the NTP Website
The NIEHS Division of Translational Toxicology (DTT) Office of Portfolio Strategy provides leadership and support for strategic research planning, program development, and portfolio management in execution of DTT’s mission to improve public health through development of data and knowledge that are translatable, predictive, and timely.
The Office coordinates across the division to identify opportunities for applying DTT’s capabilities in pursuit of impactful research with scientific approaches that are current, innovative, and creative. There is emphasis on designing and continually optimizing a portfolio structure with a program management and governance framework that aligns DTT research projects with strategic initiatives, improves operational efficiency, and maximizes public health impact. The Office supports portfolio analysis and priority setting, working with DTT staff to identify promising scientific opportunities and research needs and facilitate engagement with internal and external stakeholders.
OPS scientists contribute to NTP report and monograph series and publish findings in the NIEHS report series and peer-reviewed scientific literature. Staff publications can be viewed on the webpage.
Scott A. Masten, Ph.D.
Director, Office of Portfolio Strategy